The endocannabinoid system and ADHD
ADHD impacts 6-8% of youth and 3% of adults in Europe, leading to significant inattention and hyperactivity. Traditional treatments often lack consistent efficacy and cause side effects. Interest in the endocannabinoid system may provide new approaches for managing ADHD symptoms.